INFORMATION FOR
News
Congratulations to the following Yale Department of Internal Medicine faculty members, who were recently promoted, appointed, or reappointed:
The Yale Department of Internal Medicine is pleased to highlight the following promotions to professor of medicine.
Kasia Lipska, MD, MHS, was one of five experts invited to testify at the Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on December 14, 2023.
The National Institutes of Health and National Institute on Drug Abuse has awarded nearly $7 million to MPIs Tami Sullivan, PhD (Psychiatry and Public Health); E. Jennifer Edelman, MD, MHS (Internal Medicine and Public Health); and Dawn Johnson, PhD (University of Akron Department of Psychology) to study medication for opioid use disorder treatment retention among women who experience intimate partner violence.
A multidisciplinary team of researchers based at Yale will launch a series of studies aimed at accelerating understanding of bipolar disorder and generating new and more effective treatments. Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience and Professor of Psychiatry, and in the Child Study Center and of Radiology and Biomedical Imaging, will lead the research team.
Providing state-of-the-art clinical care, furthering the understanding of bone disorders, and supporting studies to improve therapies.
A research team led by Hilary Blumberg, MD, director of the Yale Mood Disorders Research Program (MDRP), has been awarded a grant for the study, “A Novel Mitochondrial Target as Therapeutic Approach for Bipolar Disorder.”
Insogna Honored with 2021 Frederic C. Bartter Award
While continuing to focus on the impacts of COVID-19, the center has enlarged its research portfolio to include new projects on the prevention of endometrial cancer in a growing cohort of women at high risk, non-opioid pain management following a cesarean section for women with opioid use disorder who are in recovery, and sex differences in stroke.
Non-communicable diseases are a leading cause of death worldwide. An interdisciplinary group at Yale has joined forces to address these diseases globally.
Kevan Herold, MD, newly named as C.N.H. Long Professor of Immunobiology and of Medicine, conducts research on the basis for autoimmune diseases and develops new therapies based on these studies. His focus has largely been in the field of autoimmune Type 1 diabetes.
Andrew Goodman, Dr. Kevan Herold, and Dr. Amy Caroline Justice were appointed to C.N.H. Long Professorships.
Connecticut Magazine’s 2019 “Best Doctors” list includes 217 Yale Medicine physicians in 50 specialties who were selected by their peers as the best in their fields.
A drug that targets the immune system can delay the onset of type 1 diabetes in people at high risk of developing the disease, said a Yale investigator who led the National Institutes of Health-funded Diabetes TrialNet study. The research is the first to show that the progression of type 1 diabetes can be slowed by two or more years with immunotherapy.
Kevan Herold, MD, professor of immunobiology and of internal medicine (endocrinology) won the Donald F. Steiner Award for Outstanding Achievement in Diabetes Research.
Type 2 diabetes is on the rise in children and teens, but treatment options for pediatric patients have remained more limited than those available to adults. In its first pediatric trial, a new drug — already used by type 2 diabetic adults — has proven effective for blood sugar control in children and teens with type 2 diabetes.
An all-afternoon symposium will be held on Monday, May 6, in memory of James D. Jamieson, MD, PhD, who died last October.
The Clinical Research Forum has presented its 2019 Top Ten Clinical Research Achievement Awards, which include work by Thomas O. Carpenter, MD, professor of pediatrics (endocrinology) and of orthopaedics and rehabilitation, and clinical professor of nursing.
In honor of Dr. Sherwin’s incredible contributions to clinical and translational research, the annual YCCI All Scholar Day has been renamed the Robert S. Sherwin YCCI All Scholar Day. Please join us for this year’s combined celebration of YCCI trainees and Bob’s incredible legacy.
Richard Kibbey, MD, PhD, associate professor of medicine (endocrinology) will be inducted into the American Society for Clinical Investigation (ASCI) in April 2019.